ST. LOUIS - Covidien, a pharmaceutical and healthcare products manufacturer, is expanding its St. Louis County operations. In Maryland Heights, a $72 million expansion will add over 12,000-sf to the existing 364,000-sf facility, including 5,000-sf for radiopharmaceutical production. Construction will begin in 2009 with completion expected in 2011. The project team includes
CH2M Hill Lockwood Greene of Englewood, Colo., and general contractor
McGrath & Associates of St. Louis. In Webster Groves, a $30 million, 9,000-sf pharmaceutical pilot plant will be built at Covidien’s research and development facility.
Clark, Richardson & Biskup of Kansas City is the architect and general contractor for the project.
Printer Friendly Version
Send to a Friend
